RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response
Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...
The 2021 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
Discovery of mechanics of drug targets for COVID-19
Scientists unravel inner workings of cell receptors involved in inflammatory diseases
RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children
Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available
RI-MUHC leads study of antiviral use in children hospitalized for influenza
Findings show that influenza antivirals are underutilized in Canadian pediatric hospitals, despite national clinical...
RI-MUHC scientist part of McGill team delivering World Alzheimer Report 2021
Alzheimer’s Disease International webinar launches report on World Alzheimer Day, September 21
RI-MUHC researcher Sasha Bernatsky leads nationwide COVID-19 vaccination study
New study will assess impact of the vaccines on Canadians with immune-mediated inflammatory disease
App-based HIV self-testing program leads to rapid detection of new infections and efficient connection to care
A unique new study shows that self-testing with the HIVSmart! program...
New cancer screening tool may help childhood cancer survivors
A novel cancer predisposition screening tool shows promise in helping doctors better predict which childhood cancer survivors may be at risk of developing...
Promising development in the fight with cancer using artificial intelligence
New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...